Search results
COVID-19 summer surge on the horizon? What Ohio experts say about FLiRT and other variants
The Enquirer via Yahoo News· 3 days agoCOVID guidelines: CDC shortens COVID-19 isolation period. What else to know Continuing to protect yourself and others susceptible to ...
COVID-19, Cannabis & Culture: The Rapid Evolution of Employment Law
New Jersey Business Magazine· 4 hours agoWhen discussing employment law in 2022, it is important to first consider its fluidity. “What we’ve...
Fauci defends his work on COVID-19, says he has an ‘open mind’ on its origins
Government Executive· 1 day agoDr. Anthony Fauci defended his decision-making during the COVID-19 pandemic on Monday, testifying...
Will a COVID booster protect me from the new COVID variant? What to know as doctors warn of a summer...
Yahoo Canada Style· 6 days agoApproximately 70 per cent of the city's senior population have not received a COVID-19 vaccine...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 1 day agoA different type of cancer vaccine is being tested in patients who already have cancer ‒ though it's...
Fauci defends his work on COVID-19, says he has an ‘open mind’ on its origins
Source New Mexico via Yahoo News· 1 day agoWASHINGTON — Dr. Anthony Fauci defended his decision-making during the COVID-19 pandemic on Monday,...
Fauci testifies about Covid-19 response
WJZY via Yahoo News· 1 day agoDr. Anthony Fauci, the former director of the National Institute of Allergy and Infectious Diseases, was in the hot seat as lawmakers pressed him on the...
Kyrie Irving took long, complicated route back to NBA Finals with Dallas Mavericks
USA TODAY Sports via Yahoo Sports· 7 hours agoWith his rebound from turbulent seasons for the Brooklyn Nets where his refusal to get the COVID-19 ...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 2 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented ...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 2 days agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
